Multiple Myeloma and Other Plasma Cell Neoplasms
2 clinical trials · Condition
◉ Watch Multiple Myeloma and Other Plasma Cell Neoplasms
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma (NCT07529782) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-03-17 |
| Longitudinal Data Registry of Plasma Cell Dyscrasia (NCT06760052) | Shanghai Zhongshan Hospital | 2023-03-01 |
Track Multiple Myeloma and Other Plasma Cell Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.